Fintel reports that on October 15, 2025, Goldman Sachs downgraded their outlook for Ibotta (NYSE:IBTA) from Neutral to Sell.

In the assessment of 12-month price targets, analysts unveil insights for Ibotta, presenting an average target of $30.14, a high estimate of $38.00, and a low estimate of $24.00. This current average ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: ...

The deal featured in this video was inspired by thecrazycouponlady.com *I am not being paid, sponsored, or perked by any ...

But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. Everyone has their own methods for finding great value opportunities, but our model ...

Your grocery bill keeps climbing, but inflation isn't entirely to blame. These 7 items carry hidden markups of 200% or more.

You can't change a car's MSRP and you can only negotiate the purchase price down so far. However, once you drive away, you'll ...

Get paid for your grocery receipts with these 6 real cash back receipt apps. Earn real money for shopping at your favorite ...

These clever holiday coupon hacks might save you big money, but stores secretly wish shoppers would stop using them.

Since its debut in the US in March 2025, Letybo has been positioned as Botox’s biggest competitor in the injection space. And ...

Opportunity Caucus, considered among the more moderate Democrats in the legislature, organized the event. The caucus was ...

Bonmati is a global superstar after winning the Ballon d'Or for the third time in a row, but it all started in a place called ...